Is Gilead Sciences, Inc. (GILD) a Buy, Sell, or Hold?
Gilead Sciences, Inc.
NASDAQ:GILD
$130.04 USD
-$1.36 (-1.04%)
- Volume
- 5.26M
- Average Volume
- 7.5M
- Market Capitalization
- $161.45B
- P/E Ratio
- 17.53
- Dividend Yield
- 2.48%
- Price Target
- $165.00
- Year High
- $157.29
- Year Low
- $107.75
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.44
- Current Ratio
- $1.97
Analyst Rating
Neutral
3 Rating Score
UPSIDE/DOWNSIDE
-21.2% DOWNSIDE
$165.00 Price Target
UPSIDE/DOWNSIDE HIGH
-27.8% DOWNSIDE
$180.00 Price Target High
UPSIDE/DOWNSIDE LOW
8.4% UPSIDE
$120.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| RBC Capital | Brian Abrahams | $120 | $129.61 | 2026-07-07 07:20 AM | -7.4% |
| HSBC | Rajesh Kumar | $155 | $131.27 | 2026-07-06 01:35 AM | 18.1% |
| RBC Capital | Brian Abrahams | $122 | $134.43 | 2026-06-01 07:47 AM | -9.2% |
| Maxim Group | Michael Okunewitch | $165 | $130.5492 | 2026-05-20 08:15 AM | 26.4% |
| Truist Financial | Gregory Renza | $155 | $141.54 | 2026-04-08 08:24 AM | 9.5% |
| Jefferies | Akash Tewari | $180 | $146.935 | 2026-03-10 05:37 AM | 22.5% |